Light therapy for cervical precancerous changes
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a light-activated therapy (called HAL-PDT) for a specific type of abnormal cervical cell change known as CIN2. It aims to see if this treatment can destroy the abnormal cells while keeping the cervix healthy, potentially avoiding surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 50
- You have been diagnosed with CIN2 (grade 2 cervical intraepithelial neoplasia) confirmed by a biopsy within the last 3 months
- Your cervix must be fully visible during a colposcopy (a special exam to look at the cervix) and the abnormal area must not extend into the cervical canal
- You are not pregnant and are willing to use reliable contraception (like condoms) during the study
- You have not had prior treatment for this condition and have no other serious gynecologic infections or conditions
- You do not have a history of porphyria, allergies to silicone or photosensitizing drugs, or conditions like cardiac pacemakers
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of managing CIN 2, a moderate precancerous change on the cervix. One option is a new procedure that uses argon plasma (a type of energized gas) to treat the area; the other is careful monitoring without immediate treatment, to see if one works better at clearing the abnormal cells.
This trial tests a light-based treatment (photodynamic therapy) for high-grade cervical precancerous changes, which may avoid the need for immediate surgery. It compares this approach to standard surgery to see if it is safe and effective.
This study tests a light-based treatment called photodynamic therapy for cervical pre-cancer (CIN2). It may help remove abnormal cells while avoiding more invasive surgery, and aims to see if this treatment is safe and works well.
This trial tests a light-based treatment (photodynamic therapy) for high-grade or persistent low-grade abnormal cells in the cervix or vagina. It aims to destroy these cells without surgery, which may be an option for patients who want to avoid more invasive procedures.
This study tests a light-based treatment called ALA-PDT to see if it can help clear precancerous cervical changes caused by HPV types 16 or 18. It may be an option to avoid more invasive procedures.
This trial tests a light-based treatment called photodynamic therapy for women with moderate to severe cervical changes (CIN3). It aims to destroy abnormal cells while saving healthy tissue.
Hear when a new Cervical Intraepithelial Neoplasia Grade 2 (CIN2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.